Limitations, agreements, and source contact

High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant · Source last updated 2017-04-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

Data was not collected, because funding was unavailable to continue study.

point Of Contact

email

zalkadh@emory.edu

organization

Barbara Ann Karmanos Cancer Institute

phone

(313) 576-8022

title

Zaid Al-Kahdimi, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice